Vaccination location:
***New as of 4/21/23***
Monovalent mRNA vaccines discontinued
Only Bivalent Pfizer/Moderna vaccines will be available along with Novavax. See FAQ for additional details
------------------------
J&J Covid Vaccine being discontinued
The CDC has decided to phase out the J&J Covid vaccine entirely which means when a provider uses up their J&J stock, they will not be able to order more. We are completely out of J&J vaccine at this time.
------------------------
Novavax approved as Booster Dose (18+)
Novavax has been approved as a first booster dose if it as been at least 6 months since completing the primary series vaccination. *Note*-the authorization is for anyone age 18+ who has completed a primary series (Pfizer/Moderna/J&J/Novavax) but has NEVER received a first booster dose.
See FAQ below.
------------------------
CDC approved and recommended Bivalent Boosters in stock
--Pfizer Bivalent booster (5+)
--Moderna Bivalent booster (18+)
CDC recommends one of the above to anyone if it has been at least 2 months since their last dose.
*NOTE* - no other boosters (ages 12+) are authorized at this time except the new Bivalent Boosters from Pfizer and Moderna. See FAQ below.
------------------------
Novavax Covid Vaccine now available (12+)
CDC approved new age group- See FAQ below
------------------------
Click the button below to schedule your Moderna vaccine. 3rd dose or booster eligible - see FAQ.
Click the button below to schedule your Novavax vaccine. Booster eligible (18+) - see FAQ.
Authorization
The CDC has taken steps to simplify COVID-19 vaccine recommendations and allow more flexibility for people at higher risk who want the option to receive an additional COVID-19 vaccine dose.
CDC’s Advisory Committee on Immunization Practices (ACIP) met on Wednesday, April 19th to discuss these COVID-19 vaccine recommendation changes, and the associated implications and implementation. Although there was no vote at this meeting, ACIP members expressed their support for these recommendations.
These changes include:
https://www.cdc.gov/media/releases/2023/s0419-covid-vaccines.html
---
Updated Pfizer EUA Fact Sheet: https://www.fda.gov/media/167212/download
Updated Moderna EUA Fact Sheet: https://www.fda.gov/media/167209/download
----------------------------------------------------------------------------------------------------------------------------
Authorization
Today, CDC’s Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo allowing Novavax monovalent COVID-19 boosters for adults.
This action gives people ages 18 years and older the option to receive a Novavax monovalent booster instead of an updated (bivalent) Pfizer-BioNTech or Moderna booster if they have completed primary series vaccination but have not previously received a COVID-19 booster—and if they cannot or will not receive mRNA vaccines.
Who can receive the Novavax as a Booster?
A first booster dose to the following individuals at least 6 months after completion of primary vaccination with an authorized or approved COVID-19 vaccine:
Some may be unable to receive an mRNA vaccine as a result of an allergy to a component of an mRNA COVID-19 vaccine, or as a result of a history of a severe allergic reaction (such as anaphylaxis) after a previous dose of an mRNA COVID-19 vaccine, or a lack of availability of an mRNA vaccine. People ages 18 and older may also choose to receive a Novavax monovalent booster if they are unwilling to receive mRNA vaccines, and would otherwise not receive a booster dose.
https://www.cdc.gov/media/releases/2022/s1019-novavax.html
---
Updated Novavax EUA Fact Sheet: https://www.fda.gov/media/159898/download
----------------------------------------------------------------------------------------------------------------------------
Authorization
Today, CDC’s Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo expanding the use of updated (bivalent) COVID-19 vaccines to children ages 5 through 11 years. This follows the Food and Drug Administration’s (FDA) authorization of updated COVID-19 vaccines from Pfizer-BioNTech for children ages 5 through 11 years, and from Moderna for children and adolescents ages 6 through 17 years.
What is a Bivalent Booster?
The updated bivalent COVID-19 vaccines contain, in equal parts, the original strain of SARS-CoV-2 plus BA.4 and BA.5 lineages of the omicron variant of SARS-CoV-2.
Who can receive the new Bivalent Booster?
Both can be given to people at least two months after the completion of any primary COVID-19 vaccine series, including Novavax and Janssen COVID-19 vaccines, or their most recent COVID-19 booster of any type.
https://www.cdc.gov/media/releases/2022/s1012-COVID-19-Vaccines.html
---
Updated Pfizer EUA Fact Sheet: https://www.fda.gov/media/153716/download
Updated Moderna EUA Fact Sheet: https://www.fda.gov/media/144638/download
----------------------------------------------------------------------------------------------------------------------------
Authorization
On August 31, 2022, the Food and Drug Administration (FDA) amended emergency use authorizations (EUAs) of the Pfizer and Moderna COVID-19 vaccines to authorize updated, bivalent formulations of the vaccines for use as a single booster dose. Subsequently, the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) issued interim clinical considerations, which were endorsed by CDC Director Rochelle Walensky on 9/1/22.
What is a Bivalent Booster?
The updated bivalent COVID-19 vaccines contain, in equal parts, the original strain of SARS-CoV-2 plus BA.4 and BA.5 lineages of the omicron variant of SARS-CoV-2.
Who can receive the new Bivalent Booster?
Both can be given to people at least two months after the completion of any primary COVID-19 vaccine series, including Novavax and Janssen COVID-19 vaccines, or their most recent COVID-19 booster of any type.
---
Updated Pfizer EUA Fact Sheet: https://www.fda.gov/media/153716/download
Updated Moderna EUA Fact Sheet: https://www.fda.gov/media/144638/download
----------------------------------------------------------------------------------------------------------------------------
CDC approves Novavax for ages 12+:
On 8/22/22- CDC Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo that Novavax’s COVID-19 vaccine be used as another primary series option for adolescents ages 12 through 17.
How it works: Unlike the mRNA and vector vaccines, this is a protein adjuvant (an adjuvant is an ingredient used to strengthen the immune response). While other vaccines trick the body’s cells into creating parts of the virus that can trigger the immune system, the Novavax vaccine takes a different approach. It contains the spike protein of the coronavirus itself, but formulated as a nanoparticle, which cannot cause disease. When the vaccine is injected, this stimulates the immune system to produce antibodies and T-cell immune responses. https://www.yalemedicine.org/news/covid-19-vaccine-comparison#:~:text=How%20it%20works%3A%C2%A0Unlike,and%20T%2Dcell%20immune%20responses.
Novavax- Fact Sheet for Recipients and Caregivers
----------------------------------------------------------------------------------------------------------------------------
No problem! You can still get the vaccine for free. When you arrive for your appointment, you'll simply check the "uninsured" section on our form when you're completing your paperwork.
Yes. We'd be happy to provide your second dose
PeopleFirst Pharmacy
2501 E Hebron Pkwy
Carrollton, TX 75010
Make sure you've created your appointment above and received confirmation of your appointment.
Email us at covid19@trinityapothecary.com
Copyright © 2021 Trinity Apothecary - All Rights Reserved.